COX and PPAR - Possible interactions in pancreatic cancer

[1] Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA2-IIA expression in alveolar macrophages through NF-κB and PPAR-γ-dependent pathways [J]. MOLECULAR PHARMACOLOGY, 2002, 61 (04) : 786 - 794

[2] Anderson KE, 2002, J NATL CANCER I, V94, P1168, DOI 10.1093/jnci/94.15.1168

[3] Aoki T, 2002, ONCOL REP, V9, P761

[4] COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) : 13926 - 13931

[5] Chu JS, 2003, MOL CANCER THER, V2, P1

[6] 15-deoxy-Δ12,14PGJ2 induces diverse biological responses via PPARγ activation in cancer cells [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 62 (01): : 23 - 32

[7] Magnitude of peroxisome proliferator-activated receptor-γ activation is associated with important and seemingly opposite biological responses in breast cancer cells [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2001, 49 (05) : 413 - 420

[8] Interleukin 1β induces type II-secreted phospholipase A2 gene in vascular smooth muscle cells by a nuclear factor κB and peroxisome proliferator-activated receptor-mediated process [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) : 23085 - 23093

[9] Crosby Colin G, 2003, Expert Opin Emerg Drugs, V8, P1

[10] Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer [J]. LANCET ONCOLOGY, 2001, 2 (09) : 544 - 551

[1] Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA2-IIA expression in alveolar macrophages through NF-κB and PPAR-γ-dependent pathways [J]. MOLECULAR PHARMACOLOGY, 2002, 61 (04) : 786 - 794

[2] Anderson KE, 2002, J NATL CANCER I, V94, P1168, DOI 10.1093/jnci/94.15.1168

[3] Aoki T, 2002, ONCOL REP, V9, P761

[4] COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) : 13926 - 13931

[5] Chu JS, 2003, MOL CANCER THER, V2, P1

[6] 15-deoxy-Δ12,14PGJ2 induces diverse biological responses via PPARγ activation in cancer cells [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 62 (01): : 23 - 32

[7] Magnitude of peroxisome proliferator-activated receptor-γ activation is associated with important and seemingly opposite biological responses in breast cancer cells [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2001, 49 (05) : 413 - 420

[8] Interleukin 1β induces type II-secreted phospholipase A2 gene in vascular smooth muscle cells by a nuclear factor κB and peroxisome proliferator-activated receptor-mediated process [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) : 23085 - 23093

[9] Crosby Colin G, 2003, Expert Opin Emerg Drugs, V8, P1

[10] Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer [J]. LANCET ONCOLOGY, 2001, 2 (09) : 544 - 551